Fradin, J., Haugen, A., Yang, Y., Kidwell, A., Szabó, A., McKenna, E., Cheng, Y. C. (2026). Adjuvant trastuzumab with or without pertuzumab after pathologic complete response to neoadjuvant HER2-targeted therapy and chemotherapy in HER2-positive breast cancer: A retrospective cohort study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12503